The Intercept missile launch could boost other biotech stocks as traders figure that's the sector where you can make big bucks fast. Peace & good health, Bulba
ICPT jumped again - probably as a result of the Q CC last night where the CEO pointed out that they have specific and strong results (with the same drug) in other indication (e.g. Crohns).
(Note: I didn't vet all the claims, but will say that I vetted some. Certainly would have been worthy of follow up when this was a $1.2B company -ng-)
ICPT, which has 45 employees*, now has an EV of about $9B on a fully-diluted basis. That’s $200 million of EV per employee, which must be close to a record in terms of this rather meaningless metric.